1 Min Read
Nov 15 (Reuters) - Tapimmune Inc
* Tapimmune provides third quarter 2017 corporate and clinical update
* Tapimmune Inc - qtrly loss earnings per share $0.39 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.